Introduction
Health disparities in the American healthcare system continue to be some of the most acute social problems. One manifestation of this issue is the disproportionate negative impact of systemic lupus erythematosus (SLE) on pregnancy in women of color (WoC). Compared to white females, WoC in the United States have significantly higher SLE incidence rates, reducing their likelihood of successful pregnancy. Furthermore, WoC face additional health complications, including the presence of comorbid conditions and decreased chances of conceiving. Ultimately, the negative impact of SLE on pregnancy in WoC is a relevant problem in the United States, and new methodologies to mitigate health disparities are critical.
Likelihood to Conceive
Lupus presents considerable and disproportionate difficulties to WoC who want to get pregnant. In general, SLE is a chronic, systemic autoimmune condition that negatively affects all aspects of life in affected individuals (Nusbaum et al., 2020). This problem is particularly amplified in women of reproductive age, meaning that sex-specific considerations are necessary for treatment.
Furthermore, according to Nusbaum et al. (2020), the incidence rates of SLE in Black women are approximately 2-4 times higher than in White women in the United States. At the same time, the prevalence of SLE in Hispanic and Asian females is slightly higher than the average for the mainstream population, but the difference is not statistically significant (Nusbaum et al., 2020). Based on the data, it is evident that Black women constitute the most vulnerable group regarding the incidence rates of SLE.
One of the most detrimental impacts of lupus on the female body is reduced fertility. The research finds that SLE, lupus nephritis, side effects of prescribed drugs in SLE, and age-related conditions are all frequent problems encountered by women who want to conceive (Nusbaum et al., 2020). In this context, Angley et al. (2020) emphasize that some treatments for SLE, such as cyclophosphamide, are particularly detrimental to female fertility. Experts note that more research is needed to investigate the specific mechanisms underlying the association between SLE and the likelihood of conceiving; however, the data provide credible evidence that lupus is harmful.
These findings are paramount to the present paper and the state of the academic research on SLE. First, they confirm that WoC face disproportionate risks of experiencing adverse effects of lupus on pregnancy, with Black women being the most vulnerable group (Nusbaum et al., 2020). Secondly, the findings indicate the need for further research to establish the exact connection between SLE and fertility. Finally, the mentioned results provide valuable data for determining the treatment for SLE, as some methodologies are detrimental to pregnancy, and women might want to choose alternatives. Ultimately, SLE presents significant challenges for WoC who wish to conceive.
Pregnancy Maintenance
The second critical issue is the negative impact of SLE on pregnancy maintenance in WoC. Even if women affected by lupus can successfully conceive, their pregnancy might be significantly complicated by the autoimmune condition. As Saulescu et al. (2022) dutifully note, “It (SLE) exposes the mother to severe, organ-threatening complications and unpredictable evolution” (p. 1). Namely, the threats of flares, preeclampsia, spontaneous abortion, preterm birth, and pregnancy loss are elevated significantly by up to five times higher (Nusbaum et al., 2020).
Experts also note that these problems affect African-American and Hispanic women more frequently due to socioeconomic and genetic differences, which are two critical variables of health disparities (Nusbaum et al., 2020). Besides nonwhite race, researchers also indicate low platelet count and the use of drugs to mitigate hypertension as some of the most relevant risk factors that complicate pregnancy maintenance in SLE (Nusbaum et al., 2020). Therefore, it is evident that lupus hurts both fertility and the likelihood of a successful pregnancy.
These findings are significant because they contribute to general knowledge of the topic and incentivize the development of innovative treatment methodologies to mitigate the impact of SLE during pregnancy. These scientific advancements are particularly critical to WoC given the heightened threats. Furthermore, while experts recognize that maternal outcomes in women with SLE have improved drastically in the last sixty years for the general population, the problem is still acute for Black and Hispanic women (Nusbaum et al., 2020).
At present, research indicates that these vulnerable populations face both genetic predispositions and socioeconomic factors, which must be addressed to mitigate the impact of lupus on WoC. It is imperative to continue the studies to identify all risk factors further and propose practical solutions to minimize the scope of the healthcare issue and help women achieve successful pregnancies.
Comorbid Conditions
Finally, while lupus can directly harm fertility and pregnancy maintenance, some experts believe that comorbid conditions present even more relevant hazards to female bodies. Namely, pregnancy presents critical challenges to the human organism, and any autoimmune disorder elevates these risks to the extreme (Saulescu et al., 2022). Furthermore, SLE is highly heterogeneous, meaning that it can affect most organs and worsen chronic conditions in patients (Saulescu et al., 2022).
For this reason, medical professionals do not recommend pursuing pregnancy for many women who have prominent risk factors, such as hypertension, diabetes, kidney disease, maternal diseases, high BMI, >40 years of age, and family history of preeclampsia (Saulescu et al., 2022). Otherwise, SLE might lead to pregnancy complications and various comorbid conditions.
The first group of comorbidities should be considered in the preconception stage, as the woman’s health at the time of conception is one of the most vital factors that determine the likelihood of a successful pregnancy. This category includes flares, hypertension, lupus rash, arthritis, serositis, high-risk antiphospholipid antibody profiles, lung diseases, recent thrombotic events, and lack of necessary vaccinations (Saulescu et al., 2022). As seen from the list, comorbid conditions that might cause additional complications are diverse, ranging from musculoskeletal to cardiovascular diseases, further confirming the utmost danger presented by SLE for pregnancy. To estimate the scope of risk factors, women who wish to conceive must undergo comprehensive screening and clinical assessment, including physical exams, laboratory evaluations, potential drug interaction checks, vaccinations, and antibody testing (Saulescu et al., 2022). These procedures are essential to minimize the impact of SLE and comorbid conditions on pregnancy maintenance.
If women with SLE decide to continue the pregnancy, they might encounter additional challenges and additional comorbidities. In this context, diabetes, hypertension, and renal disease are some of the most acute comorbid conditions that present significant risks to overall health status, potentially causing long-term damage (Saulescu et al., 2022). The likelihood of emerging comorbidities and their impact also depends on the pregnancy timeline, with unique challenges during each trimester (Saulescu et al., 2022).
Ultimately, this information is critical because it transparently conveys the threats posed by SLE before and during pregnancy. Women who want to become mothers must undergo meticulous screenings to ensure that comorbid conditions do not lead to reduced health outcomes. While it is a prerequisite for pregnancy for all women, this problem is more acute for WoC, who are at higher risk of developing SLE and comorbid conditions. Improved access to tests, lab evaluations, and preconception counseling is necessary to mitigate health disparities nationwide. In summary, SLE causes diverse negative impacts on female bodies, and it is imperative to minimize the threats through comprehensive screenings and proactive approaches.
Conclusion
The present paper has confirmed that women of color with SLE have disproportionate risks regarding fertility, pregnancy maintenance, and overall health status compared to White females. It is a relevant problem since health disparities are still highly prominent in the United States, and WoC frequently have reduced socioeconomic capabilities. Based on this information, it is evident that innovative, evidence-based approaches are necessary to improve pregnancy outcomes for WoC with SLE and to support all women who want to become mothers.
Furthermore, it is essential to address the underlying socioeconomic factors to reduce the impact of health disparities on the American population as a whole. Finally, more initiatives are required in the context of screening for risk factors, as comorbid conditions pose additional threats to pregnancy and overall health outcomes. WoC are exposed to even greater risks due to limited access in the contemporary healthcare system. In conclusion, SLE is a highly detrimental condition that negatively affects all stages of pregnancy, and there is a substantial need to provide better support for WoC living with lupus.
References
Angley, M., Lim, S. S., Spencer, J. B., & Howards, P. P. (2020). Infertility among African American women with systemic lupus erythematosus compared to healthy women: A pilot study. Arthritis Care & Research, 72(9), 1275-1281.
Nusbaum, J. S., Mirza, I., Shum, J., Freilich, R. W., Cohen, R. E., Pillinger, M. H., Izmirly, P. M., & Buyon, J. P. (2020). Sex differences in systemic lupus erythematosus: epidemiology, clinical considerations, and disease pathogenesis. Mayo Clinic Proceedings, 95(2), 384-394.
Saulescu, I. C., Opris-Belinski, D., Balanescu, A. R., Pavel, B., Gica, N., & Panaitescu, A. M. (2022). Preparing for pregnancy in women with systemic lupus erythematosus– A multidisciplinary approach. Medicina, 58(10), 1-17.